ProfileGDS5068 / 203273_s_at
TitleRheumatoid arthritic synovium response to tocilizumab
OrganismHomo sapiens


baseline tocilizumab patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 GSM1116933 GSM1116935 GSM1116937 GSM1116939 GSM1116941 GSM1116943 GSM1116945 GSM1116947 GSM1116949 GSM1116951 GSM1116953 GSM1116955 GSM1116934 GSM1116936 GSM1116938 GSM1116940 GSM1116942 GSM1116944 GSM1116946 GSM1116948 GSM1116950 GSM1116952 GSM1116954 GSM1116956 19% 64% 45% 77% 68% 85% 79% 22% 39% 73% 93% 48% 86% 40% 43% 89% 30% 49% 30% 29% 32% 23% 11% 34% sort by agent sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1116933Synovial tissue prior to Tocilizumab therapy, repl 1-0.20861819
GSM1116935Synovial tissue prior to Tocilizumab therapy, repl 20.061114364
GSM1116937Synovial tissue prior to Tocilizumab therapy, repl 3-0.018352545
GSM1116939Synovial tissue prior to Tocilizumab therapy, repl 40.15745177
GSM1116941Synovial tissue prior to Tocilizumab therapy, repl 50.080415768
GSM1116943Synovial tissue prior to Tocilizumab therapy, repl 60.21409885
GSM1116945Synovial tissue prior to Tocilizumab therapy, repl 70.2110879
GSM1116947Synovial tissue prior to Tocilizumab therapy, repl 8-0.15464322
GSM1116949Synovial tissue prior to Tocilizumab therapy, repl 9-0.050792739
GSM1116951Synovial tissue prior to Tocilizumab therapy, repl 100.10428373
GSM1116953Synovial tissue prior to Tocilizumab therapy, repl 110.35696593
GSM1116955Synovial tissue prior to Tocilizumab therapy, repl 12-0.0026159348
GSM1116934Synovial tissue after to Tocilizumab therapy, repl 10.31344486
GSM1116936Synovial tissue after to Tocilizumab therapy, repl 2-0.031963840
GSM1116938Synovial tissue after to Tocilizumab therapy, repl 3-0.023881943
GSM1116940Synovial tissue after to Tocilizumab therapy, repl 40.42647689
GSM1116942Synovial tissue after to Tocilizumab therapy, repl 5-0.10685330
GSM1116944Synovial tissue after to Tocilizumab therapy, repl 6-0.0014109649
GSM1116946Synovial tissue after to Tocilizumab therapy, repl 7-0.12876730
GSM1116948Synovial tissue after to Tocilizumab therapy, repl 8-0.10898829
GSM1116950Synovial tissue after to Tocilizumab therapy, repl 9-0.091046832
GSM1116952Synovial tissue after to Tocilizumab therapy, repl 10-0.13038123
GSM1116954Synovial tissue after to Tocilizumab therapy, repl 11-0.22230111
GSM1116956Synovial tissue after to Tocilizumab therapy, repl 12-0.066320434